122 related articles for article (PubMed ID: 19633548)
1. Novel treatment of medullary thyroid cancer.
Sugawara M; Geffner DL; Martinez D; Hershman JM
Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):367-72. PubMed ID: 19633548
[TBL] [Abstract][Full Text] [Related]
2. XL184 (cabozantinib) for medullary thyroid carcinoma.
Durante C; Russo D; Verrienti A; Filetti S
Expert Opin Investig Drugs; 2011 Mar; 20(3):407-413. PubMed ID: 21314233
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract][Full Text] [Related]
5. Update on medullary thyroid cancer.
Hu MI; Ying AK; Jimenez C
Endocrinol Metab Clin North Am; 2014 Jun; 43(2):423-42. PubMed ID: 24891170
[TBL] [Abstract][Full Text] [Related]
6. Transient partial response to sorafenib treatment in an adolescent patient with MEN2B syndrome and end-stage medullary thyroid carcinoma.
Aller S; Popescu A; Rao S; Morgan E; Gosiengfiao Y
Pediatr Blood Cancer; 2012 Jan; 58(1):98-100. PubMed ID: 21721105
[TBL] [Abstract][Full Text] [Related]
7. [Use of new molecules in the treatment of advanced thyroid cancer].
Galofré JC; Gómez-Sáez JM; Álvarez Escola C; Álvarez García E; Anda Apiñaniz E; Calleja A; Donnay S; Lucas-Martin A; Menéndez Torre E; Navarro González E; Pereg V; Pérez Corral B; Santamaría Sandi J; Riesco Eizaguirre G; Zafón Llopis C;
Endocrinol Nutr; 2011 Oct; 58(8):381-6. PubMed ID: 21924966
[No Abstract] [Full Text] [Related]
8. Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer.
Schlumberger MJ; Elisei R; Bastholt L; Wirth LJ; Martins RG; Locati LD; Jarzab B; Pacini F; Daumerie C; Droz JP; Eschenberg MJ; Sun YN; Juan T; Stepan DE; Sherman SI
J Clin Oncol; 2009 Aug; 27(23):3794-801. PubMed ID: 19564535
[TBL] [Abstract][Full Text] [Related]
9. How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy.
Fagin JA
J Endocrinol; 2004 Nov; 183(2):249-56. PubMed ID: 15531713
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma metastatic to skin.
Nashed C; Sakpal SV; Cherneykin S; Chamberlain RS
J Cutan Pathol; 2010 Dec; 37(12):1237-40. PubMed ID: 19615004
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
Schlumberger M; Abdelmoumene N; Delisle MJ; Couette JE
Br J Cancer; 1995 Feb; 71(2):363-5. PubMed ID: 7530987
[TBL] [Abstract][Full Text] [Related]
12. Mixed follicular and parafollicular thyroid carcinoma.
Vitri P; Galimberti A; De Pasquale L; Vago L; Boldorini R; Bastagli A
J Exp Clin Cancer Res; 1999 Dec; 18(4):567-9. PubMed ID: 10746987
[TBL] [Abstract][Full Text] [Related]
13. [Metastasis of medullar thyroid carcinoma (case report)].
Moutaouakil A; Baha AT; Amraoui A
Bull Soc Belge Ophtalmol; 2003; (288):19-22. PubMed ID: 12879721
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of metastatic medullary thyroid gland carcinoma with the somatostatin analog octreotide].
Frank-Raue K; Raue F; Ziegler R
Med Klin (Munich); 1995 Feb; 90(2):63-6. PubMed ID: 7708002
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Quayle FJ; Moley JF
J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide.
Lupoli G; Cascone E; Arlotta F; Vitale G; Celentano L; Salvatore M; Lombardi G
Cancer; 1996 Sep; 78(5):1114-8. PubMed ID: 8780551
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma and hormones.
Cohen R; Quidville V; Bihan H
Ann Med Interne (Paris); 2003 Mar; 154(2):109-16. PubMed ID: 12746649
[TBL] [Abstract][Full Text] [Related]
18. Combretastatin A-4 and doxorubicin combination treatment is effective in a preclinical model of human medullary thyroid carcinoma.
Nelkin BD; Ball DW
Oncol Rep; 2001; 8(1):157-60. PubMed ID: 11115589
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of cabozantinib for the treatment of thyroid cancer.
Karras S; Pontikides N; Krassas GE
Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):507-15. PubMed ID: 23488614
[TBL] [Abstract][Full Text] [Related]
20. Medullary thyroid carcinomas in cell culture--models for future therapies.
Pfragner R; Wirnsberger GH; Ingolic E; Niederle B
Wien Klin Wochenschr; 2002 Apr; 114(7):279-83. PubMed ID: 12089864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
